Yaupon Thereapeutics is a privately held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories.  The company's lead program, Clearazide, is completing Phase III trials for the treatment of Cutaneous T-cell lymphonma (CTCL).Website: http://www.yaupontherapeutics.com